Tirzepatide
Price range: $80.00 (USD) through $260.00 (USD)
GLP-2TZ is a synthetic peptide investigated and used clinically for its incretin-based metabolic activity, designed to activate key pathways involved in glycemic control and appetite regulation.
As a dual incretin receptor agonist (GIP/GLP‑1), it is associated with clinically meaningful effects on body weight and metabolic markers in studied populations.
This injectable peptide is typically positioned for advanced metabolic research where receptor-driven appetite and glucose signaling are the primary focus.
Tirzepatide overview
GLP-2TZ is an incretin-mimetic peptide developed to engage metabolic hormone signaling pathways relevant to glucose homeostasis and energy intake.
Its pharmacology is commonly described through dual receptor activity (GIP and GLP‑1), with downstream effects that influence appetite, post‑meal glucose excursions, and overall metabolic efficiency.
Metabolic research focus
In clinical research and real-world medical settings, GLP-2TZ has been associated with substantial reductions in body weight alongside improvements in glycemic endpoints in type 2 diabetes and obesity-focused studies.
Because these outcomes are mediated by receptor-specific signaling, GLP-2TZ is often highlighted in discussions around next-generation incretin therapies and cardiometabolic risk modification.
Status and safety note
GLP-2TZ is a potent bioactive compound; product positioning should clearly separate research/product information from medical guidance, and avoid consumer-facing dosing claims.
Any safety statements should remain conservative (e.g., “effects and risks depend on context and individual factors”) unless backed by jurisdiction-specific labeling.
Frequently Asked Questions About GLP-2TZ
What is GLP-2TZ?
GLP-2TZ is a dual GIP/GLP-1 receptor agonist peptide used in metabolic research. It’s a 39-amino acid synthetic peptide designed to study glucose metabolism, insulin sensitivity, and weight regulation mechanisms.
What purity level is your GLP-2TZ ?
Our research-grade GLP-2TZ is manufactured in the USA with >99% purity, verified through HPLC and mass spectrometry. Each batch includes third-party testing documentation.
What vial sizes are available for GLP-2TZ?
We offer GLP-2TZ in multiple research dosages: 5mg, 10mg, and 15mg vials to accommodate different research protocol requirements.
How should GLP-2TZ be stored?
Store lyophilized GLP-2TZ at -20°C to -80°C. After reconstitution with bacteriostatic water, store at 2-8°C (refrigerated) and use within 28 days for optimal stability.
How do you reconstitute GLP-2TZ ?
For a 10mg vial, add 2ml of bacteriostatic water to achieve a 5mg/ml concentration. Inject water slowly along the vial wall, swirl gently (do not shake), and allow 2-5 minutes to fully dissolve.
How does GLP-2TZ differ from GLP-1SG?
GLP-2TZ is a dual GIP/GLP-1 agonist, while GLP-1SG is a selective GLP-1 agonist. GLP-2TZ dual mechanism provides unique research opportunities in studying combined incretin receptor activation.
What research applications is GLP-2TZ used for?
GLP-2TZ is utilized in metabolic research, glucose homeostasis studies, insulin sensitivity investigations, appetite regulation research, and studies examining incretin receptor pathways.
Is GLP-2TZ stable after reconstitution?
When reconstituted with bacteriostatic water and stored properly at 2-8°C, GLP-2TZ maintains stability for up to 28 days. Avoid freeze-thaw cycles and protect from light.
Related Products
Cagrisema is a potent new blend, a combination that integrates two peptides – cagrilintide and semaglutide.
Semaglutide is a GLP-1 receptor agonist; a version of human GLP-1 hormone, modified to resist the degradation by the enzyme dipeptidyl peptidase-4.
Cagrilintdide, on the other hand, is an amylin analogue. Its role is to mimic the human hormone amylin and is structurally designed to be resistant to enzymatic degradation.
Together, these two peptides profoundly influence chemical structures and induce hormonal changes:
- Leading to the receptor changes within the pancreas and the brain
- Boosting insulin secretion
- Interacting with the receptors involved in appetite regulation
- Mimicking the action of amylin
- Decreasing glucagon secretion
All in all, this is a sophisticated, more importantly, incredibly potent combination of two peptides whose actions complement each other. Cagrisema combination influences some key hormonal processes and plays a role in metabolic regulation.
GLP-1SG is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that GLP-1SG may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with GLP-1SG has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
Size: 5mg / 10mg
Contents: GLP-1SG
Form: Lyophilized powder
Purity: >99%
GLP-3RT is an investigational multi-receptor agonist peptide designed to target multiple metabolic hormone pathways involved in appetite, energy expenditure, and glucose regulation.
It is most often described as a next-generation approach to weight-management research due to its combined incretin and glucagon-pathway activity.
This injectable peptide is primarily referenced in the context of clinical development and advanced metabolic research.
Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of the endogenous alpha-melanocyte-stimulating hormone (α-MSH).
In research settings, it is widely utilized to investigate the melanocortin system’s role in regulating skin pigmentation (melanogenesis), sexual behavior, and energy homeostasis (appetite suppression) through non-selective activation of melanocortin receptors.
Note: This product is intended for research use only and is not for human consumption.
Buy Cagrilintide Online
Cagrilintide is a long-acting amylin analogue, currently at the forefront of peptide research due to its rather interesting potential beneficial effect in individuals with diabetes. But what’s so special about amylin? Well, amylin is another peptide hormone, co-secreted with insulin, which inhibits food intake, delays gastric emptying, and, most importantly, reduces blood glucose levels.
Back to cagrilintide… it was originally developed to improve on the initial amylin analogue called pramlintide. The problem with pramlintide is its short half-life and undesired side effects.
Cagrilintide was (and still is being) developed to alter the half-life, potency and stability of pramlintide, and other amylin analogues.Since, it’s still a relatively new peptide, it still needs to undergo further research so we can make sure its as effective and safe.
AOD9604 is a derivative of human growth hormone (hGH) and a modified version of the hGH fragment 176-191 peptide, incorporating a di-sulfide bridge. What’s exciting about this peptide is that it does not affect IGF-1 or insulin levels and is, therefore, not a risk in promoting glucose intolerance.
Sermorelin (GHRH 1-29) is a synthetic peptide analogue of the endogenous growth hormone-releasing hormone (GHRH). It consists of the first 29 amino acids of the native neurohormone and retains full biological activity in stimulating the pituitary gland.
In research settings, Sermorelin is utilized to study the regulation of pulsatile growth hormone (GH) secretion and the feedback mechanisms of the hypothalamic-pituitary-somatotropic axis.
Note: This product is intended for research use only and is not for human consumption.
